Plasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in Thailand

NCT ID: NCT05328479

Last Updated: 2022-10-19

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 5181 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2021-11-04
• Study Completion Date: 2022-05-20

Brief Summary

The investigators assessed the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation.

Detailed Description

The investigators aimed to assess the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation. The investigators compared the population between the age groups 12-18 years, 18-45 years and over 45 years to monitor the symptoms of coronavirus patients treated in home isolation and long-term symptoms including factors related to the patient's recovery in the past, present, and future.

Conditions

COVID-19

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: RETROSPECTIVE

Eligibility Criteria

Inclusion Criteria

1. patient with infected with the novel coronavirus disease 2019 (COVID-19) who has been end of self-quarantine at Siriraj Hospital more than 21 days.

2. Thai nationality, able to read and write Thai language

3. able to use telephone and line to communicate

Exclusion Criteria

1. people who received additional vaccination after leaving quarantine before the day of the immunization test

• Minimum Eligible Age: 12 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Mahidol University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Korapat Mayurasakorn, MD.

Role: PRINCIPAL_INVESTIGATOR

Doctor in Family Medicine

Locations

Faculty of Medicine Siriraj Hospital, Mahidol University

Bangkok Noi, Bangkok, Thailand

Countries

Thailand

Other Identifiers

769/2564(IRB1)

Identifier Type: -

Identifier Source: org_study_id